Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis
- PMID: 20333418
- DOI: 10.1007/s00774-010-0164-5
Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis
Abstract
The purpose of this study was to clarify the effects of 2-year treatment with raloxifene on the proximal femoral geometry among Japanese patients with osteoporosis by hip structure analysis. One hundred ninety-eight community-dwelling postmenopausal women with osteoporosis were enrolled. The structural variables were areal bone mineral density (BMD), cross-sectional area (CSA), section modulus (index of resistance to bending forces), and buckling ratio (index of cortical instability). BMD, CSA, and section modulus at the narrow neck significantly increased by 1.27, 2.67, and 3.90% at 2 years, respectively. BMD, CSA, and section modulus at the intertrochanter significantly increased by 2.55, 4.49, and 6.60% at study termination, respectively. The buckling ratio at the intertrochanter decreased by 2.36% at 1 year, but differences at 2 years became non-significant. Parameters at the shaft were qualitatively similar to those of the narrow neck and intertrochanter. The percent change of the section modulus was significantly higher than that of BMD at 2 years in all three regions. The percent changes of the section modulus is strongly correlated with the percent changes of BMD and CSA, and negative correlated with the percent changes of buckling ratio in all regions. In conclusion, Japanese osteoporotic women on raloxifene therapy have significant improvements of both BMD and geometry in the proximal femur.
Similar articles
-
Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis.J Bone Miner Metab. 2011 Jul;29(4):458-65. doi: 10.1007/s00774-010-0242-8. Epub 2010 Nov 30. J Bone Miner Metab. 2011. PMID: 21116831
-
Correlation between a bone resorption marker and structural geometry of the proximal femur in osteoporotic women treated with raloxifene.J Orthop Surg (Hong Kong). 2012 Aug;20(2):209-13. doi: 10.1177/230949901202000215. J Orthop Surg (Hong Kong). 2012. PMID: 22933681
-
Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial.Osteoporos Int. 2006;17(4):575-86. doi: 10.1007/s00198-005-0028-3. Epub 2006 Jan 4. Osteoporos Int. 2006. PMID: 16392026 Clinical Trial.
-
The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis.Bone. 2015 Aug;77:115-9. doi: 10.1016/j.bone.2015.04.027. Epub 2015 Apr 23. Bone. 2015. PMID: 25917574 Clinical Trial.
-
[Effects of SERMs on bone health. The effects of raloxifene on bone quality evaluated by hip structure analysis].Clin Calcium. 2010 Mar;20(3):355-63. Clin Calcium. 2010. PMID: 20190365 Review. Japanese.
Cited by
-
Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia).Clin Interv Aging. 2014 Nov 5;9:1879-93. doi: 10.2147/CIA.S70307. eCollection 2014. Clin Interv Aging. 2014. PMID: 25395843 Free PMC article.
-
The SERM raloxifene improves diaphyseal fracture healing in mice.J Bone Miner Metab. 2013 Nov;31(6):629-36. doi: 10.1007/s00774-013-0461-x. Epub 2013 Apr 2. J Bone Miner Metab. 2013. PMID: 23546819
-
Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis.J Bone Miner Metab. 2011 Jul;29(4):458-65. doi: 10.1007/s00774-010-0242-8. Epub 2010 Nov 30. J Bone Miner Metab. 2011. PMID: 21116831
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical